Abscopal effect in a Hodgkin lymphoma patient treated by an anti-programmed death 1 antibody

Jean Marie Michot; Renaud Mazeron; Laurent Dercle; Samy Ammari; Charles Canova; Aurelien Marabelle; Shelonitda Rose; Eric Rubin; Eric Deutsch; Jean Charles Soria; Vincent Ribrag; Antonin Levy

doi:10.1016/j.ejca.2016.06.017

Abscopal effect in a Hodgkin lymphoma patient treated by an anti-programmed death 1 antibody

Jean Marie Michot, Renaud Mazeron, Laurent Dercle, Samy Ammari, Charles Canova, Aurelien Marabelle, Shelonitda Rose, Eric Rubin, Eric Deutsch, Jean Charles Soria, Vincent Ribrag, Antonin Levy

Résultats de recherche: Contribution à un journal › Letter › Revue par des pairs

54 Citations (Scopus)

langue originale	Anglais
Pages (de - à)	91-94
Nombre de pages	4
journal	European Journal of Cancer
Volume	66
Les DOIs	https://doi.org/10.1016/j.ejca.2016.06.017
état	Publié - 1 oct. 2016

Accès au document

10.1016/j.ejca.2016.06.017

Autres fichiers et liens

Lien vers la publication dans Scopus

Contient cette citation

@article{64790b6b4eb746dd96cd8f5608575a4d,

title = "Abscopal effect in a Hodgkin lymphoma patient treated by an anti-programmed death 1 antibody",

keywords = "Abscopal effect, Hodgkin disease, Irradiation, Out-of-field, PD-1, Pembrolizumab",

author = "Michot, {Jean Marie} and Renaud Mazeron and Laurent Dercle and Samy Ammari and Charles Canova and Aurelien Marabelle and Shelonitda Rose and Eric Rubin and Eric Deutsch and Soria, {Jean Charles} and Vincent Ribrag and Antonin Levy",

note = "Funding Information: This study was funded by Merck & Co., Inc. , Kenilworth, NJ, USA. The funders of the study had no role in the writing of the report. The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit for publication. ",

year = "2016",

month = oct,

day = "1",

doi = "10.1016/j.ejca.2016.06.017",

language = "English",

volume = "66",

pages = "91--94",

journal = "European Journal of Cancer",

issn = "0959-8049",

}

TY - JOUR

T1 - Abscopal effect in a Hodgkin lymphoma patient treated by an anti-programmed death 1 antibody

AU - Michot, Jean Marie

AU - Mazeron, Renaud

AU - Dercle, Laurent

AU - Ammari, Samy

AU - Canova, Charles

AU - Marabelle, Aurelien

AU - Rose, Shelonitda

AU - Rubin, Eric

AU - Deutsch, Eric

AU - Soria, Jean Charles

AU - Ribrag, Vincent

AU - Levy, Antonin

N1 - Funding Information: This study was funded by Merck & Co., Inc. , Kenilworth, NJ, USA. The funders of the study had no role in the writing of the report. The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit for publication.

PY - 2016/10/1

Y1 - 2016/10/1

KW - Abscopal effect

KW - Hodgkin disease

KW - Irradiation

KW - Out-of-field

KW - PD-1

KW - Pembrolizumab

UR - http://www.scopus.com/inward/record.url?scp=84982124874&partnerID=8YFLogxK

U2 - 10.1016/j.ejca.2016.06.017

DO - 10.1016/j.ejca.2016.06.017

M3 - Letter

C2 - 27544928

AN - SCOPUS:84982124874

SN - 0959-8049

VL - 66

SP - 91

EP - 94

JO - European Journal of Cancer

JF - European Journal of Cancer

ER -